EpCAM is highly and frequently expressed in the vast majority of carcinomas that have been analyzed [11, 12] and its expression in metastases frequently correlates with levels in the corresponding primary tumors (Fig. 4 and [13, 14, 21, 55]). Here, EPCAM is linked to carcinoma.